Highbridge Capital Management LLC Zoetis Inc. Transaction History

Highbridge Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$83.5 - $93.23 $228,623 - $255,263	-2,738 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $298,426 - $333,162	-3,735 Reduced 57.7%	2,738 $233,000
Q1 2018 May 15, 2018	SELL	$71.51 - $84.69 $7.29 Million - $8.63 Million	-101,923 Reduced 94.03%	6,473 $541,000
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $6.47 Million - $7.09 Million	108,396	108,396 $6.91 Million

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.